A nonsense mutation in the ERG6 gene leads to reduced susceptibility to polyenes in a clinical isolate of Candida glabrata

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 10, 2008, Pages 3701-3709

  Vandeputte, Patrick ^a,b   Tronchin, Guy ^a   Larcher, Gérald ^a   Ernoult, Emilie ^a,d   Bergès, Thierry ^c   Chabasse, Dominique ^a,b   Bouchara, Jean Philippe ^a,b  

^a UNIVERSITÉ D'ANGERS   (France)

^b ANGERS UNIVERSITY HOSPITAL   (France)

^c UNIVERSITÉ DE POITIERS   (France)

^d CENTRE PAUL PAPIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ECONAZOLE; ERGOSTEROL; FLUCONAZOLE; KETOCONAZOLE; MICONAZOLE; NYSTATIN; POLYENE ANTIBIOTIC AGENT; PYRROLE DERIVATIVE; VORICONAZOLE;

ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CANDIDA GLABRATA; CELL ULTRASTRUCTURE; CELL VIABILITY; CELL WALL; ERG6 GENE; FITNESS; FUNGAL GENE; FUNGUS HYPHAE; GAS CHROMATOGRAPHY; GENE EXPRESSION; GENETIC COMPLEMENTATION; NONHUMAN; NONSENSE MUTATION; NUCLEOTIDE SEQUENCE; PLASMID; PRIORITY JOURNAL; PROTEIN TRANSPORT; SEQUENCE ANALYSIS;

EID: 54049154731     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00423-08     Document Type: Article

References (33)

1. Barker, K. S., S. Crisp, N. Wiederhold, R. E. Lewis, B. Bareither, J. Eckstein, R. Barbuch, M. Bard, and P. D. Rogers. 2004. Genome-wide expression profiling reveals genes associated with amphotericin B and fluconazole resistance in experimentally induced antifungal resistant isolates of Candida albicans. J. Antimicrob. Chemother. 54:376-385.
2. Bouchara, J. P., R. Zouhair, S. Le Boudouil, G. Renier, R. Filmon, D. Chabasse, J. N. Hallet, and A. Defontaine. 2000. In-vivo selection of an azole-resistant petite mutant of Candida glabrata. J. Med. Microbiol. 49:977-984.
3. Bouvier-Navé, P., T. Husselstein, and P. Benveniste. 1998. Two families of sterol methyltransferases are involved in the first and the second methylation steps of plant sterol biosynthesis. Eur. J. Biochem. 256:88-96.
4. Brun, S., T. Bergès, P. Poupard, C. Vauzelle-Moreau, G. Renier, D. Chabasse, and J. P. Bouchara. 2004. Mechanisms of azole resistance in petite mutants of Candida glabrata. Antimicrob. Agents Chemother. 48:1788-1796.
5. Casey, W. M., J. P. Burgess, and L. W. Parks. 1991. Effect of sterol sidechain structure on the feed-back control of sterol biosynthesis in yeast. Biochim. Biophys. Acta 1081:279-284.
6. Cheng, S., C. J. Clancy, K. T. Nguyen, W. Clapp, and M. H. Nguyen. 2007. A Candida albicans petite mutant strain with uncoupled oxidative phosphorylation overexpresses MDR1 and has diminished susceptibility to fluconazole and voriconazole. Antimicrob. Agents Chemother. 51:1855-1858.
7. Defontaine, A., J. P. Bouchara, P. Declerk, C. Planchenault, D. Chabasse, and J. N. Hallet. 1999. In-vitro resistance to azoles associated with mitochondrial DNA deficiency in Candida glabrata. J. Med. Microbiol. 48:663-670.
8. Ellis, D. 2002. Amphotericin B: spectrum and resistance. J. Antimicrob. Chemother. 1:7-10.
9. Fidel, P. L., Jr., J. A. Vazquez, and J. D. Sobel. 1999. Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin. Microbiol. Rev. 12:80-96.
10. Geraghty, P., and K. Kavanagh. 2003. Disruption of mitochondrial function in Candida albicans leads to reduced cellular ergosterol levels and elevated growth in the presence of amphotericin B. Arch. Microbiol. 179:295-300.
11. Jensen-Pergakes, K. L., M. A. Kennedy, N. D. Lees, R. Barbuch, C. Koegel, and M. Bard. 1998. Sequencing, disruption, and characterization of the Candida albicans sterol methyltransferase (ERG6) gene: drug susceptibility studies in erg6 mutants. Antimicrob. Agents Chemother. 42:1160-1167.
12. Kanafani, Z. A., and J. R. Perfect. 2008. Antimicrobial resistance: resistance to antifungal agents: mechanisms and clinical impact. Clin. Infect. Dis. 46:120-128.
13. Kaur, R., R. Domergue, M. L. Zupancic, and B. P. Cormack. 2005. A yeast by any other name: Candida glabrata and its interaction with the host. Curr. Opin. Microbiol. 8:378-384.
14. Kelly, S. L., D. C. Lamb, D. E. Kelly, N. J. Manning, J. Loeffler, H. Hebart, U. Schumacher, and H. Einsele. 1997. Resistance to fluconazole and crossresistance to amphotericin B in Candida albicans from AIDS patients caused by defective delta 5,6-desaturation. FEBS Lett. 400:80-82.
15. Kuranda, K., V. Leberre, S. Sokol, G. Palamarczyk, and J. François. 2006. Investigating the caffeine effects in the yeast Saccharomyces cerevisiae brings new insights into the connection between TOR, PKC and Ras/cAMP signalling pathways. Mol. Microbiol. 61:1147-1166.
16. Lees, N. D., B. Skaggs, D. R. Kirsch, and M. Bard. 1995. Cloning of the late genes in the ergosterol biosynthetic pathway of Saccharomyces cerevisiae - a review. Lipids 30:221-226.
17. Marchler-Bauer, A., J. B. Anderson, M. K. Derbyshire, C. DeWeese-Scott, N. R. Gonzales, M. Gwadz, L. Hao, S. He, D. I. Hurwitz, J. D. Jackson, Z. Ke, D. Krylov, C. J. Lanczycki, C. A. Liebert, C. Liu, F. Lu, S. Lu, G. H. Marchler, M. Mullokandov, J. S. Song, N. Thanki, R. A. Yamashita, J. J. Yin, D. Zhang, and S. H. Bryant. 2007. CDD: a conserved domain database for interactive domain family analysis. Nucleic Acids Res. 35:237-240.
18. Marchler-Bauer, A., and S. H. Bryant. 2004. CD-Search: protein domain annotations on the fly. Nucleic Acids Res. 32:327-331.
19. Nes, W. D. 2003. Enzyme mechanisms for sterol C-methylations. Phytochemistry 64:75-95.
20. Nes, W. D., P. Jayasimha, W. Zhou, R. Kanagasabai, C. Jin, T. T. Jaradat, R. W. Shaw, and J. M. Bujnicki. 2004. Sterol methyltransferase: functional analysis of highly conserved residues by site-directed mutagenesis. Biochemistry 43:569-576.
21. Nes, W. D., A. Sinha, P. Jayasimha, W. Zhou, Z. Song, and A. L. Dennis. 2006. Probing the sterol binding site of soybean sterol methyltransferase by site-directed mutagenesis: functional analysis of conserved aromatic amino acids in region 1. Arch. Biochem. Biophys. 448:23-30.
22. Niimi, M., K. Niimi, Y. Takano, A. R. Holmes, F. J. Fischer, Y. Uehara, and R. D. Cannon. 2004. Regulated overexpression of CDR1 in Candida albicans confers multidrug resistance. J. Antimicrob. Chemother. 6:999-1006.
23. Nolte, F. S., T. Parkinson, D. J. Falconer, S. Dix, J. Williams, C. Gilmore, R. Geller, and J. R. Wingard. 1997. Isolation and characterization of fluconazole-and amphotericin B-resistant Candida albicans from blood of two patients with leukemia. Antimicrob. Agents Chemother. 44:196-199.
24. Odds, F. C., M. G. Rinaldi, C. R. Cooper, Jr., A. Fothergill, L. Pasarell, and M. R. McGinnis. 1997. Candida and Torulopsis: a blinded evaluation of use of pseudohypha formation as basis for identification of medically important yeasts. J. Clin. Microbiol. 35:313-316.
25. Pasrija, R., S. L. Panwar, and R. Prasad. 2008. Multidrug transporters CaCdr1p and CaMdr1p of Candida albicans display different lipid specificities: both ergosterol and sphingolipids are essential for targeting of CaCdr1p to membrane rafts. Antimicrob. Agents Chemother. 52:694-704.
26. Richardson, M. D. 2005. Changing patterns and trends in systemic fungal infections. J. Antimicrob. Chemother. 56:i5-i11.
27. Sanglard, D., F. Ischer, T. Parkinson, D. Falconer, and J. Bille. 2003. Candida albicans mutations in the ergosterol biosynthetic pathway and resistance to several antifungal agents. Antimicrob. Agents Chemother. 47:2404-2412.
28. Sanglard, D., and F. C. Odds. 2002. Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. Lancet Infect. Dis. 2:73-85.
29. Servouse, M., and F. Karst. 1986. Regulation of early enzymes of ergosterol biosynthesis in Saccharomyces cerevisiae. Biochem. J. 240:541-547.
30. Umebayashi, K., and A. Nakano. 2003. Ergosterol is required for targeting of tryptophan permease to the yeast plasma membrane. J. Cell Biol. 161:1117-1131.
31. Vandeputte, P., G. Larcher, T. Bergès, G. Renier, D. Chabasse, and J. P. Bouchara. 2005. Mechanisms of azole resistance in a clinical isolate of Candida tropicalis. Antimicrob. Agents Chemother. 49:4608-4615.
32. Vandeputte, P., G. Tronchin, T. Bergès, C. Hennequin, D. Chabasse, and J. P. Bouchara. 2007. Reduced susceptibility to polyenes associated with a missense mutation in the ERG6 gene in a clinical isolate of Candida glabrata with pseudohyphal growth. Antimicrob. Agents Chemother. 51:982-990.
33. Watson, P. F., M. E. Rose, and S. L. Kelly. 1998. Isolation and analysis of ketoconazole resistant mutants of Saccharomyces cerevisiae. J. Med. Vet. Mycol. 3:153-162.